
UNH
UnitedHealth Group Incorporated · NYSE
$512.60+0.97%
9 Sep close- Market cap
- $472B
- Sector
- Health care
Cash flow
Operating, investing and financing cash flows
Loading

| Twelve months to | Q3 FY21 | Q4 FY21 | Q1 FY22 | Q2 FY22 | Q3 FY22 | Q4 FY22 | Q1 FY23 | Q2 FY23 | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period ending | 30 Sep 21 | 31 Dec 21 | 31 Mar 22 | 30 Jun 22 | 30 Sep 22 | 31 Dec 22 | 31 Mar 23 | 30 Jun 23 | 30 Sep 23 | 31 Dec 23 | 31 Mar 24 | 30 Jun 24 | 30 Sep 24 | 31 Dec 24 | 31 Mar 25 | 30 Jun 25 | 30 Sep 25 | 31 Dec 25 | 31 Mar 26 | 30 Jun 26 | Each line by period |
| Net income | $16.1B | $16.1B | $16.2B | $16.3B | $16.4B | $16.5B | $16.7B | $17.0B | $17.2B | $17.5B | $17.6B | $17.8B | $17.9B | $18.0B | $18.3B | $18.5B | $18.8B | $19.1B | $19.4B | $19.8B | |
| Depreciation and amortisation | $3.1B | $3.2B | $3.3B | $3.4B | $3.5B | $3.6B | $3.7B | $3.8B | $4.0B | $4.1B | $4.2B | $4.2B | $4.3B | $4.4B | $4.5B | $4.5B | $4.6B | $4.7B | $4.8B | $4.9B | |
| Share-based compensation | $0.8B | $0.9B | $0.9B | $0.9B | $0.9B | $1.0B | $1.0B | $1.0B | $1.1B | $1.1B | $1.1B | $1.2B | $1.2B | $1.2B | $1.2B | $1.2B | $1.3B | $1.3B | $1.3B | $1.3B | |
| Working capital and other | −$1.6B | −$1.8B | −$1.9B | −$2.0B | −$2.1B | −$2.2B | −$2.4B | −$2.5B | −$2.7B | −$2.8B | −$2.6B | −$2.3B | −$2.0B | −$1.7B | −$1.7B | −$1.7B | −$1.7B | −$1.7B | −$1.3B | −$0.9B | |
| Cash from operating activities | $18.4B | $18.3B | $18.4B | $18.5B | $18.7B | $18.8B | $19.1B | $19.4B | $19.6B | $19.9B | $20.4B | $20.9B | $21.4B | $21.9B | $22.3B | $22.6B | $23.0B | $23.4B | $24.2B | $25.1B | |
| Capital expenditure | −$2.2B | −$2.3B | −$2.4B | −$2.4B | −$2.5B | −$2.6B | −$2.7B | −$2.8B | −$2.9B | −$3.0B | −$3.0B | −$3.1B | −$3.1B | −$3.2B | −$3.3B | −$3.3B | −$3.4B | −$3.4B | −$3.5B | −$3.5B | |
| Acquisitions, net of cash acquired | −$7.9B | −$9.9B | −$9.4B | −$8.8B | −$8.2B | −$7.6B | −$8.7B | −$9.9B | −$11.1B | −$12.3B | −$11.7B | −$11.0B | −$10.3B | −$9.6B | −$8.8B | −$8.1B | −$7.3B | −$6.5B | −$8.3B | −$10.1B | |
| Buy-backs, dividends and other returns | −$12.7B | −$12.5B | −$12.6B | −$12.7B | −$12.8B | −$12.8B | −$13.1B | −$13.3B | −$13.5B | −$13.7B | −$13.8B | −$13.9B | −$14.0B | −$14.2B | −$14.4B | −$14.6B | −$14.8B | −$15.0B | −$15.3B | −$15.5B | |
| Debt issued, net of repayments | $4.8B | $6.5B | $6.5B | $6.5B | $6.5B | $6.5B | $6.5B | $6.5B | $6.5B | $6.5B | $6.5B | $6.5B | $6.5B | $6.5B | $6.5B | $6.5B | $6.5B | $6.5B | $6.5B | $6.5B | |
| Other investing and financing, net | $0.9B | $1.3B | $0.8B | $0.2B | −$0.3B | −$0.9B | $0.2B | $1.4B | $2.6B | $4.0B | $3.0B | $2.0B | $0.9B | −$0.2B | −$1.0B | −$1.8B | −$2.7B | −$3.6B | −$2.4B | −$1.1B | |
| Net change in cash and investments | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B | |
| Free cash flow | $16.2B | $16.0B | $16.0B | $16.1B | $16.1B | $16.2B | $16.4B | $16.6B | $16.8B | $16.9B | $17.3B | $17.8B | $18.2B | $18.7B | $19.0B | $19.3B | $19.6B | $19.9B | $20.7B | $21.6B | |
| Derived metrics | |||||||||||||||||||||
| Free cash flow as a share of revenue | 5.8% | 5.6% | 5.4% | 5.3% | 5.1% | 5.0% | 4.9% | 4.8% | 4.7% | 4.5% | 4.6% | 4.6% | 4.6% | 4.7% | 4.7% | 4.7% | 4.7% | 4.7% | 4.8% | 4.9% | |
| Capital expenditure as a share of revenue | 0.8% | 0.8% | 0.8% | 0.8% | 0.8% | 0.8% | 0.8% | 0.8% | 0.8% | 0.8% | 0.8% | 0.8% | 0.8% | 0.8% | 0.8% | 0.8% | 0.8% | 0.8% | 0.8% | 0.8% | |
Billions of dollars. Outflows are negative. Capital expenditure as a share of revenue is on its magnitude, as it is normally quoted.